Please assess the completion status of the following clinical trial:

Trial Title: Pharmacokinetics of Progesterone in Pregnancy-2

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age ≥18yo~* Singleton gestation, ≥36 0/7 weeks gestation~* Scheduled cesarean delivery at Thomas Jefferson University Hospital or affiliate~Exclusion Criteria:~* Contraindication to vaginal progesterone suppository~  * Active hepatic disease~ * Prior or current thrombus~ * Known adverse reaction to progesterone~ * Peanut allergy~* Bleeding disorder (such as thrombophilia)~* Use of 17-hydroxyprogesterone caproate in the pregnancy~* Use of vaginal progesterone in the pregnancy~* History of adverse reaction to progesterone~* Current vaginitis

- Gender: FEMALE
- Minimum Age: 16 Years
- Maximum Age: 55 Years
- Healthy Volunteers: t

Study Arms:
- Vaginal progesterone (Type: ACTIVE_COMPARATOR): 200mg micronized vaginal progesterone placed 7am prior to scheduled cesarean delivery
- Control (Type: NO_INTERVENTION): No intervention, scheduled cesarean delivery

Based on this trial design, predict the completion outcome and termination type (if applicable).